Amid mounting concerns about the spread of mpox, an experimental vaccine from Moderna may be poised to offer additional protection beyond currently available vaccines, research published Wednesday shows.
					 Previous ArticleFactory orders rise in July after two months of weakness
				
				
	Related Posts
			
				Add A Comment			
		
	
	